Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (301-310 of 329) with videos related to

Pageof 33
Sort By:
Chest|February 22, 2024
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial AsthmaCendrine Godet, Anne-Laure Brun, Francis Couturaud, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2024
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study)Mathilde Jacob, Pierre Fournel, Claire Tissot, et al.
The European Respiratory Journal|August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patientsMyriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platformsMichèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.
Thorax|September 27, 2023
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohortAxelle Mabo, Raphael Borie, Lidwine Wemeau-Stervinou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.
The European Respiratory Journal|March 3, 2022
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statementEva Van Braeckel, Iain Page, Jesper Rømhild Davidsen, et al.
Lancet (London, England)|January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
The European Respiratory Journal|September 4, 2024
Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trialLaurène Mansy, Agnès Caille, Martine Reynaud-Gaubert, et al.
BMC Gastroenterology|September 11, 2023
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendationsJean-François David Cadranel, Isabelle Ollivier-Hourmand, Jacques Cadranel, et al.
Pageof 33

Showing results (301-310 of 329) with videos related to

Sort By:
Pageof 33
Chest|February 22, 2024
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial AsthmaCendrine Godet, Anne-Laure Brun, Francis Couturaud, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2024
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study)Mathilde Jacob, Pierre Fournel, Claire Tissot, et al.
The European Respiratory Journal|August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patientsMyriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platformsMichèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.
Thorax|September 27, 2023
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohortAxelle Mabo, Raphael Borie, Lidwine Wemeau-Stervinou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.
The European Respiratory Journal|March 3, 2022
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statementEva Van Braeckel, Iain Page, Jesper Rømhild Davidsen, et al.
Lancet (London, England)|January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
The European Respiratory Journal|September 4, 2024
Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trialLaurène Mansy, Agnès Caille, Martine Reynaud-Gaubert, et al.
BMC Gastroenterology|September 11, 2023
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendationsJean-François David Cadranel, Isabelle Ollivier-Hourmand, Jacques Cadranel, et al.
Pageof 33